Bracco pushes for use of PET-based rubidium for heart scans

10/11/2009 | Diagnostic Imaging

Bracco Diagnostics is actively promoting the use of positron-based rubidium for heart scans as an alternative to the use of gamma-based technetium, which is currently in short supply. Bracco's CardioGen-82 generator of rubidium isotopes is the only available product for generator-based PET myocardial perfusion imaging approved by the FDA. The company said it can supply enough CardioGen-82 to address the demand for clinical cardiac scans during the ongoing shortage.

View Full Article in:

Diagnostic Imaging

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC